CN1188166C - Medicine for treating skin disease and its preparing method - Google Patents
Medicine for treating skin disease and its preparing method Download PDFInfo
- Publication number
- CN1188166C CN1188166C CNB031535127A CN03153512A CN1188166C CN 1188166 C CN1188166 C CN 1188166C CN B031535127 A CNB031535127 A CN B031535127A CN 03153512 A CN03153512 A CN 03153512A CN 1188166 C CN1188166 C CN 1188166C
- Authority
- CN
- China
- Prior art keywords
- medicine
- percent
- treatment
- cimetidine
- trypsin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 208000017520 skin disease Diseases 0.000 title abstract description 6
- 238000000034 method Methods 0.000 title abstract description 3
- 229940079593 drug Drugs 0.000 title description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 32
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 claims abstract description 14
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims abstract description 14
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960001380 cimetidine Drugs 0.000 claims abstract description 14
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229960000282 metronidazole Drugs 0.000 claims abstract description 14
- 229940025250 camphora Drugs 0.000 claims abstract description 13
- 239000010238 camphora Substances 0.000 claims abstract description 13
- 102000004142 Trypsin Human genes 0.000 claims abstract description 11
- 108090000631 Trypsin Proteins 0.000 claims abstract description 11
- 239000012588 trypsin Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229940097572 chloromycetin Drugs 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- 101710151387 Serine protease 1 Proteins 0.000 claims description 3
- 102100032491 Serine protease 1 Human genes 0.000 claims description 3
- 101710119665 Trypsin-1 Proteins 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 3
- 206010000496 acne Diseases 0.000 abstract description 10
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 8
- 201000004624 Dermatitis Diseases 0.000 abstract description 7
- 206010016936 Folliculitis Diseases 0.000 abstract description 6
- 208000008742 seborrheic dermatitis Diseases 0.000 abstract description 5
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract description 4
- 239000002537 cosmetic Substances 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 229960005091 chloramphenicol Drugs 0.000 abstract 2
- 206010004542 Bezoar Diseases 0.000 abstract 1
- 241000723346 Cinnamomum camphora Species 0.000 abstract 1
- 238000009098 adjuvant therapy Methods 0.000 abstract 1
- 229960000846 camphor Drugs 0.000 abstract 1
- 229930008380 camphor Natural products 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 238000011084 recovery Methods 0.000 description 5
- 239000002674 ointment Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical class C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical class CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 229940098166 bactrim Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000002201 cell of epidermis Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 229960000860 dapsone Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- RGLYKWWBQGJZGM-ISLYRVAYSA-N diethylstilbestrol Chemical compound C=1C=C(O)C=CC=1C(/CC)=C(\CC)C1=CC=C(O)C=C1 RGLYKWWBQGJZGM-ISLYRVAYSA-N 0.000 description 1
- 229960000452 diethylstilbestrol Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009786 epithelial differentiation Effects 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940043263 traditional drug Drugs 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
A medicine for treating skin diseases comprises the following components in parts by weight: 0.5 to 1.5 percent of bezoar, 0.5 to 1.5 percent of trypsin, 0.5 to 1.5 percent of metronidazole, 0.5 to 1.5 percent of chloramphenicol, 0.5 to 1.5 percent of cimetidine, 1.0 to 2.0 percent of camphor and 70 to 80 percent of alcohol are added to 100 ml. A method for preparing a medicine for treating skin diseases comprises: mixing metronidazole, chloramphenicol and cimetidine; dissolving Camphora in ethanol; dissolving calculus bovis and trypsin in small amount of water; after the three steps are completed, adding alcohol to the full amount and uniformly mixing. The invention has compound treatment function, not only has the function of treating skin diseases, but also can be used for preventing dermatitis and being used as a cosmetic. Can be used for the comprehensive treatment of skin, and the treatment or adjuvant treatment of various skin intractable diseases, and has good therapeutic effect on various acne, seborrheic dermatitis, folliculitis, dermatitis caused by mite, and acne.
Description
Technical field
The present invention relates to dermopathic medicine of a kind of treatment and preparation method.
Background technology
Dermatitis that acne, skin sore, seborrheic dermatitis, folliculitis, acarid cause and acne are common skin diseases, and the dermopathic traditional drug of existing this class of treatment has following a few class: one, oral medicine: 1, antimicrobial drug: tetracycline, erythromycin, gram force mycin, bactrim etc.; 2, anti-inflammatory agent: corticosteroid hormone, dapsone, ibuprofen class, formonitrile HCN rice melon, Radix Salviae Miltiorrhizae Tabellae or injection etc.; 3, press down fat medicine and the normal medicine of short keratinization: vitamin A, the suitable retinoic acid (isomery retinoic acid) of D, 13-etc.; 4, anti-androgen medicine: diethylstilbestrol, oral contraceptive, potent gynotermone derivant; 5, vitamin E, B
2, B
6Deng; Two, medicine for external use: compound sulfur lotion, 5% sulphur ointment, 20% thiosulfonic acid sodium solution, 10% YUSHIZHI RUANGAO, 2～5% benzoyl peroxides (benzoyl peroxide ointment), antiiotic ointment etc.Medicine for external use needs and oral medicine is used, the patient usually wants outer simultaneously and wipes and several medicines for oral administration, each medicine function singleness, therapeutic process is very loaded down with trivial details, these oral medicine have side effect such as some gastrointestinal reactions, sexual hormone disturbance again in addition, sixty-four dollar question is that curative effect is not remarkable, is difficult to play ideal treatment for skin stubborn disease and imitates, and does not still have the like product of Chinese medicine, Western medicine, three unifications of biochemical medicine at present.
Summary of the invention
The invention provides dermopathic medicine of a kind of treatment and preparation method thereof, the existing treatment of solution dermatitis action of drug is single, therapeutic process is loaded down with trivial details, side effect is big, the inapparent technical problem of curative effect.
A kind of technical scheme for the treatment of dermopathic medicine of the present invention: its composition and mixing ratio by weight are: Calculus Bovis 0.5～1.5%, trypsin 0.5～1.5%, metronidazole 0.5～1.5%, chloromycetin 0.5～1.5%, cimetidine 0.5～1.5%, Camphora 1.0～2.0%, 70～80% ethanol add to 100ml.
Above-mentioned a kind of composition and preferred mixing ratio by weight for the treatment of dermopathic medicine is: Calculus Bovis 1%, trypsin 1%, metronidazole 1%, chloromycetin 1%, cimetidine 1%, Camphora 1.5%, 75% ethanol add to 100ml.
This a kind of preparation method for the treatment of dermopathic medicine is characterized in that preparation method is as follows:
A, proportioning by weight ratio are got metronidazole 0.5～1.5%, chloromycetin 0.5～1.5%, cimetidine 0.5～1.5% mixing;
B, Camphora 1.0～2.0% add 70～80% ethanol mixed dissolutions;
C, Calculus Bovis 0.5～1.5%, trypsin 0.5～1.5% add the low amounts of water dissolving;
After d, above-mentioned three steps are finished, add ethanol to the 100ml mix homogeneously.
Beneficial effect: the dermopathic medicine of a kind of treatment mainly comprises Calculus Bovis, trypsin, metronidazole, chloromycetin, cimetidine, Camphora, ethanol.Calculus Bovis has heat-clearing toxin-expelling functions, is usually used in treating diseases such as catching a cold, get angry; Trypsin has the effect of the peptide chain of decomposition, can dissolve Denatured protein, promotes epithelial cell differentiation and growth, strengthens the human metabolism function, removes the withered horn cell of epidermis; Metronidazole has bactericidal action, and can kill acarid; Chloromycetin is broad spectrum antibiotic, and good antiinflammation is arranged; Cimetidine can suppress seborrhea; Camphora can promote local blood circulation, and antiinflammation is arranged.These several compositions combine and be prepared into the dermopathic medicine of a kind of treatment in ethanol, have the combination therapy function, and the effect of treatment dermatosis is not only arranged, and also can be used for preventing dermatitis, be used as cosmetics.Can carry out synthesis treatment for skin, can treat or auxiliary treatment various skin pertinacious disease, the dermatitis that all kinds of acnes, skin sore, seborrheic dermatitis, folliculitis, acarid are caused and acne etc. all have better therapeutic effect.
Detect through Yantai City's health measuring station: the every regulation (examining report of seeing Appendix) that meets [defending the method prison sends out (2002) No. 229], " cosmetics health standard ".
The part model case of proof curative effect of the present invention:
1, Xing Shuyu, the woman, 45 years old, to suffer from surplus facial seborrheic dermatitis, the folliculitis 10 year, use the dermopathic medicine of a kind of treatment in May, 2003, is clearly better behind the first quarter moon, fully recovers after one month.
2, Wang Shiying, the man, 35 years old, fore head more serious folliculitis and skin sore occurred with face in 5 years, used the dermopathic medicine of a kind of treatment in May, 2003, used to be clearly better after two months a continuation use recovery from illness in month again.
3, Liu Yunfang, the woman, 46 years old, after the front face acne was cured substantially in 10 years, have repeatedly once in a while, and stay blackhead and skin dark stain, use the dermopathic medicine of a kind of treatment in June, 2003, through about 40 days wiping, the acne recovery from illness, facial blackhead and skin dark stain disappear.
4, Liu Yuling, the woman, 20 years old, began to occur acne and skin sore from 17 years old, use skinice in May, 2003, and after one month there be not repeatedly so far recovery from illness.
5, Wang Yunbo, the man, 28 years old, beginning before about 4 years, head, face and chest and back suffer from more serious folliculitis, and use the dermopathic medicine of a kind of treatment in March, 2003, uses promptly to occur in three weeks being clearly better, and continues to use the back recovery from illness of three weeks again.
6, Lv Xiaoyun, the woman 25 years old, begins to occur skin sore in the time of 18 years old, and suffer from acarid dermatitis, also used the relevant cosmetics and the medicine that remove acarid, but DeGrain, after using the dermopathic medicine of a kind of treatment in April, 2003, the obvious effect of about 20 daybreaks is used less than a recovery from illness in month.
Mentioned component and ratio all can not arbitrarily increase and decrease.Usage and consumption: preferably earlier affected part is cleaned and wiped driedly, dip in a kind of treatment dermopathic medicine wiping affected part three time with small brushes or cotton balls every day.The serious symptom person can five times, have no adverse reaction.
The specific embodiment
Embodiment one: a kind of composition and mixing ratio by weight for the treatment of dermopathic medicine is: Calculus Bovis 0.5～1.5%, trypsin 0.5～1.5%, metronidazole 0.5～1.5%, chloromycetin 0.5～1.5%, cimetidine 0.5～1.5%, Camphora 1.0～2.0%, 70～80% ethanol add to 100ml.
The preferred main component ratio of the dermopathic medicine of a kind of treatment: Calculus Bovis 1%, trypsin 1%, metronidazole 1%, chloromycetin 1%, cimetidine 1%, Camphora 1.5%, 75% ethanol add to 100ml.
The Calculus Bovis consumption also can select 0.6%, 0.7%, 0.8%, 0.9%, 1.1%, 1.2%, 1.3%, 1.4%;
The trypsin consumption also can select 0.6%, 0.7%, 0.8%, 0.9%, 1.1%, 1.2%, 1.3%, 1.4%;
The metronidazole consumption also can select 0.6%, 0.7%, 0.8%, 0.9%, 1.1%, 1.2%, 1.3%, 1.4%;
The chloromycetin consumption also can select 0.6%, 0.7%, 0.8%, 0.9%, 1.1%, 1.2%, 1.3%, 1.4%;
The cimetidine consumption also can select 0.6%, 0.7%, 0.8%, 0.9%, 1.1%, 1.2%, 1.3%, 1.4%;
The Camphora consumption also can select 1.1%, 1.2%, 1.3%, 1.4%, 1.6%, 1.7%, 1.8%, 1.9%, 2.1%, 2.2%, 2.3%, 2.4%.
A kind of preparation method embodiment that treats dermopathic medicine of the present invention: the proportioning by weight ratio, get metronidazole 0.5～1.5%, chloromycetin 0.5～1.5%, cimetidine 0.5～1.5% mixing; Camphora 1.0～2.0% adds 70～80% ethanol mixed dissolutions; Calculus Bovis 0.5～1.5%, trypsin 0.5～1.5% add the low amounts of water dissolving; After above-mentioned three steps are finished, add ethanol to the 100ml mix homogeneously.
Claims (3)
1, the dermopathic medicine of a kind of treatment is characterized in that composition and mixing ratio by weight are: Calculus Bovis 0.5～1.5%, trypsin 0.5～1.5%, metronidazole 0.5～1.5%, chloromycetin 0.5～1.5%, cimetidine 0.5～1.5%, Camphora 1.0～2.0%, 70～80% ethanol add to 100ml.
2, the dermopathic medicine of a kind of treatment according to claim 1 is characterized in that its composition and preferred mixing ratio by weight are: Calculus Bovis 1%, trypsin 1%, metronidazole 1%, chloromycetin 1%, cimetidine 1%, Camphora 1.5%, 75% ethanol add to 100ml.
3, a kind of preparation method for the treatment of dermopathic medicine is characterized in that preparation method is as follows:
A, proportioning by weight ratio are got metronidazole 0.5～1.5%, chloromycetin 0.5～1.5%, cimetidine 0.5～1.5% mixing;
B, Camphora 1.0～2.0% add 70～80% ethanol mixed dissolutions;
C, Calculus Bovis 0.5～1.5%, trypsin 0.5～1.5% add the low amounts of water dissolving;
After d, above-mentioned three steps are finished, add ethanol to the 100ml mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031535127A CN1188166C (en) | 2003-08-15 | 2003-08-15 | Medicine for treating skin disease and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031535127A CN1188166C (en) | 2003-08-15 | 2003-08-15 | Medicine for treating skin disease and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1483474A CN1483474A (en) | 2004-03-24 |
| CN1188166C true CN1188166C (en) | 2005-02-09 |
Family
ID=34156706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031535127A Expired - Fee Related CN1188166C (en) | 2003-08-15 | 2003-08-15 | Medicine for treating skin disease and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1188166C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101822827A (en) * | 2010-05-13 | 2010-09-08 | 仵小南 | Preparation for cosmetic dermatology and scar repairing |
-
2003
- 2003-08-15 CN CNB031535127A patent/CN1188166C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1483474A (en) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6955816B2 (en) | Anti-aging skin care composition and uses thereof | |
| US20040156873A1 (en) | Topically Bioavailable Acne and Rosacea Treatment Compositions | |
| US20060013845A1 (en) | Oxygenated personal care products | |
| EP1639991A2 (en) | Skin and tissue care and/or treatment composition | |
| DE60314722T2 (en) | COMPOSITION FOR PHARMACEUTICAL OR DIETARY USE TO PREVENT HAIR LOSS | |
| EP1527770B1 (en) | A cosmetic mask composition | |
| DE10036797A1 (en) | Use of combinations containing carnitines | |
| DE60003541T2 (en) | Process for promoting skin cell metabolism | |
| US9993510B2 (en) | Acne-removing traditional chinese medicine composition and preparation method thereof | |
| CN101773511B (en) | Compound topical combination drug for treatment of acne and preparation method thereof | |
| KR20000046633A (en) | Composition for treatment of atopic dermatonosis | |
| CN1411360A (en) | Method of treating skin conditions | |
| CN1188166C (en) | Medicine for treating skin disease and its preparing method | |
| KR102605627B1 (en) | Leucine derivatives, composition comprising the same, and uses thereof | |
| HUE025484T2 (en) | Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris | |
| CN1116038C (en) | Exterior-applied liquid medicine for treating acne | |
| JP4018764B2 (en) | Skin preparation for improving tsunami | |
| CN100342872C (en) | A skin caring preparation for treating dermatoses, and its preparation method | |
| EP3373897A1 (en) | Skin care composition | |
| CN1253155C (en) | Whelk treating medicine composition and its preparation method | |
| EP1675586A1 (en) | Methods for treating non-microbial inflammatory skin conditions | |
| KR20050094720A (en) | The soap which it made with the natural materials which has the clause germ and a sterilization effect | |
| CN1181811C (en) | Superfine compound pearl powder cosmetic and its preparing process | |
| CN1528327A (en) | Complex external medicine speical for acne and preparing method thereof | |
| CN1393221A (en) | Liquid medicine for treating acne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: NANTONG TIANWEI BIOLOGY SCIENCE CO., LTD. Free format text: FORMER OWNER: XING DONGXING Effective date: 20050812 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20050812 Address after: 226100 Red Sun Science Park, Haimen Economic Development Zone, Jiangsu, Nantong Patentee after: Nantong Tian Wei Biological Technology Co., Ltd. Address before: 264006, No. 1, unit 35, Jincheng District, Yantai economic and Technological Development Zone, Yantai, Shandong, 1 Patentee before: Xing Dongxing |
|
| DD01 | Delivery of document by public notice |
Addressee: Shi Yan Document name: Notification that Application Deemed not to be Proposed |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050209 Termination date: 20110815 |